Pre-treatment amino acids and risk of paclitaxel-induced peripheral neuropathy in SWOG S0221-Reference-Cited by-同舟云学术

Pre-treatment amino acids and risk of paclitaxel-induced peripheral neuropathy in SWOG S0221

Published:2024-05-30 Issue:2 Volume:94 Page:311-321
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Chen Ciao-Sin^ORCID,Zirpoli Gary^ORCID,Budd G. Thomas,Barlow William E.^ORCID,Pusztai Lajos^ORCID,Hortobagyi Gabriel N.^ORCID,Albain Kathy S.^ORCID,Godwin Andrew K.^ORCID,Thompson Alastair,Henry N. Lynn^ORCID,Ambrosone Christine B.^ORCID,Stringer Kathleen A.^ORCID,Hertz Daniel L.^ORCID

Funder

American Cancer Society

National Cancer Institute, United States

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00280-024-04680-6.pdf

Reference46 articles.

1. Molassiotis A, Cheng HL, Lopez V, Au JSK, Chan A, Bandla A, Leung KT, Li YC, Wong KH, Suen LKP et al (2019) Are we mis-estimating chemotherapy-induced peripheral neuropathy? Analysis of assessment methodologies from a prospective, multinational, longitudinal cohort study of patients receiving neurotoxic chemotherapy. BMC Cancer 19(1):132

2. Seidman AD, Berry D, Cirrincione C, Harris L, Muss H, Marcom PK, Gipson G, Burstein H, Lake D, Shapiro CL et al (2008) Randomized phase III trial of weekly compared with every-3-weeks paclitaxel for metastatic breast cancer, with trastuzumab for all HER-2 overexpressors and random assignment to trastuzumab or not in HER-2 nonoverexpressors: final results of cancer and leukemia group B protocol 9840. J Clin Oncology: Official J Am Soc Clin Oncol 26(10):1642–1649

3. Rivera DR, Ganz PA, Weyrich MS, Bandos H, Melnikow J (2018) Chemotherapy-associated peripheral neuropathy in patients with early-stage breast cancer: a systematic review. J Natl Cancer Inst 110(2)

4. Hershman DL, Unger JM, Crew KD, Till C, Greenlee H, Minasian LM, Moinpour CM, Lew DL, Fehrenbacher L, Wade JL 3 et al (2018) Two-year trends of taxane-induced neuropathy in women enrolled in a randomized trial of acetyl-L-carnitine (SWOG S0715). J Natl Cancer Inst 110(6):669–676

5. Simon NB, Danso MA, Alberico TA, Basch E, Bennett AV (2017) The prevalence and pattern of chemotherapy-induced peripheral neuropathy among women with breast cancer receiving care in a large community oncology practice. Qual Life Res 26(10):2763–2772